Healthcare

Clinical Trials / Studies

Master
Content

Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. Baylor College of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.

Content

View Actively Recruiting Studies at Baylor College of Medicine trials on ClinicalTrials.gov.

Search for Clinical Trials

Administration of HIV-specific T cells to HIV+ Patients Receiving High Dose Chemotherapy Followed by Autologous Stem Cell Rescue -Auto-RESIST BMT CTN…
  • Infectious Diseases/Immune System
  • Cancer - All
  • Cancer - Lymphoma
Ex Vivo T-Cell Depletion of Mobilized peripheral blood stem cells via CD34-Selection  Participants are being asked to take part in this study…
  • Cancer - All
  • Cancer - Stem Cell Transplant
Cell Therapy for High Risk T-cell Malignancies using CD7-Specific CAR Expressed on Non-Edited T cells (CRIMSON-NE) Patients eligible for this study…
  • Cancer - All
  • Cancer - Leukemia
  • Cancer - Non-Hodgkin Lymphoma
  • Cancer - Lymphoma
Phase I study of HER2 chimeric antigen receptor (CAR) T cells in combination with checkpoint blockade in patients with advanced sarcoma (HEROS 3.0)…
  • Cancer - All
  • Cancer - Sarcoma
The purpose of this study is to find the largest safe dose of TAA-specific CTLs, to learn what the side effects are, and to see whether this therapy…
  • Cancer - All
  • Cancer - Myeloma
This research study uses special immune system cells called AGAR T cells, a new experimental treatment.
  • Pediatrics
  • Cancer - All
  • Cancer - Sarcoma
  • Cancer - Liver
The purpose of this study is to find the largest safe dose of TXSVN, to learn what the side effects are, and to see whether this therapy might help…
  • Cancer - All
  • Cancer - Myeloma
The purpose of this study is to find out the highest safe dose of allogeneic CD30.CAR-EBVST cells given following chemotherapy and used to treat…
  • Cancer - All
  • Cancer - Lymphoma
This study is a first in human Phase 1 study that involves patients with a type of cancer called HER2 (Human Epidermal Growth Factor Receptor 2)…
  • Cancer - Breast
  • Cancer - Head/Neck
  • Cancer - Gastric/Stomach
  • Cancer - Esophagus
  • Cancer - Colon/Rectal
  • Cancer - Bladder
  • Cancer - All
  • Cancer - Pancreas
  • Cancer - Lung
In this study, investigators attach the CD7 chimeric receptor with CD28 added to it to T cells that have had CD7 removed from their surface.
  • Cancer - All
  • Cancer - Leukemia